Мы должны вырубить питание главного банка данных. - Это невозможно, - сказал директор. - Вы представляете, каковы будут последствия. Джабба отлично знал, что директор прав.
Source: Romanian Medical Journal. Inverted papilloma is a rare epithelial benign neoplasm which presents a number of significant therapeutic problems due to a high rate of postoperative recurrence and a significant percentage of malignancy.
This article represents a review of the literature on this topic and a synthesis of Colțea ENT Clinic experience in inverted papilloma associated with scuamos cell carcinoma SCC. Study design.
Retrospective, between and 7 years. Inverted papilloma carcinoma of 36 patients with schneiderian papilloma treated in our clinic, 8 were identified with inverted papilloma associated with SCC.
English Copyright of Romanian Medical Inverted papilloma carcinoma is the property of Amaltea Medical Publishing House and its content may not be copied or emailed to multiple sites or posted to a listserv without the copyright holder's express written permission.
However, users may print, download, or email articles for individual use.
This abstract may be abridged. No warranty is given about the accuracy of the copy.
VI, NR. Rar este ntlnit la nivelul vestbulului, septului, rinofaringelui, sinusurilor frontale i sfenoidale sau la nivelul sacului la- crimal. Etologia papilomului invertt este necunos- cut. Au fost incriminate cauze multple precum: polipoza nazal, alergia, sinuzita cronic, factori externi carcinogeni, infecia viral.
Users should refer to the original published version of the material for the full abstract. Important User Information: Remote access to Inverted papilloma carcinoma databases is permitted to patrons inverted papilloma carcinoma subscribing institutions accessing from remote locations for personal, non-commercial use.
However, remote access to EBSCO's databases from non-subscribing institutions is not allowed if the purpose of the use is for commercial gain through cost reduction or avoidance for a non-subscribing institution.